Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More

BeiGene News

May 14, 2024

BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024

Read more

May 8, 2024

BeiGene Reports First Quarter 2024 Financial Results and Business Updates

Read more

April 26, 2024

BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report

Read more

April 24, 2024

Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting

Read more

April 23, 2024

BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer

Read more

March 14, 2024

BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy

Read more